货号:GS40736
Toripalimab is a humanized monoclonal antibody targeting programmed cell death protein 1 (PD-1). It binds to PD-1 on T cells, blocking interaction with PD-L1/PD-L2 ligands to restore anti-tumor immunity. Approved in China, it is used for various cancers including melanoma, nasopharyngeal carcinoma, urothelial carcinoma, and esophageal cancer, both as monotherapy and in combination.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯